PCSA
Price:
$2.12
Market Cap:
$4.80M
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features PCS12852, a unique selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist. This compound is currently in Phase 2A clinical trials for its potential applicat...[Read more]
Industry
Biotechnology
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
PCSA
According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -281.30%. This represents a change of 255.56% compared to the average of -79.12% of the last 4 quarters.
The mean historical ROE of Processa Pharmaceuticals, Inc. over the last ten years is -222.36%. The current -281.30% ROE has changed 26.51% with respect to the historical average. Over the past ten years (40 quarters), PCSA's ROE was at its highest in in the September 2017 quarter at 583.17%. The ROE was at its lowest in in the December 2017 quarter at -410.92%.
Average
-222.36%
Median
-152.96%
Minimum
-698.64%
Maximum
14.29%
Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 718.66%
Maximum Annual ROE = 14.29%
Minimum Annual Increase = -3581.11%
Minimum Annual ROE = -698.64%
| Year | ROE | Change |
|---|---|---|
| 2025 | -243.20% | -65.19% |
| 2024 | -698.64% | 213.41% |
| 2023 | -222.91% | -39.28% |
| 2022 | -367.09% | 718.66% |
| 2021 | -44.84% | -45.98% |
| 2020 | -83.00% | 98.05% |
| 2019 | -41.91% | 7.98% |
| 2018 | -38.81% | -92.20% |
| 2017 | -497.45% | -3581.11% |
| 2016 | 14.29% | -91.57% |
The current ROE of Processa Pharmaceuticals, Inc. (PCSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-388.25%
5-year avg
-315.34%
10-year avg
-222.36%
Processa Pharmaceuticals, Inc.’s ROE is greater than BriaCell Therapeutics Corp. (-147.92%), less than Curis, Inc. (805.67%), greater than Entero Therapeutics, Inc. (-18.69%), greater than Leap Therapeutics, Inc. (-46.86%), greater than Palisade Bio, Inc. (-36.79%), greater than Hoth Therapeutics, Inc. (-165.25%), less than Moleculin Biotech, Inc. (3.11%), greater than Athira Pharma, Inc. (-381.01%), greater than Allarity Therapeutics, Inc. (-109.94%), greater than Citius Pharmaceuticals, Inc. (-67.42%),
| Company | ROE | Market cap |
|---|---|---|
| -147.92% | $5.46M | |
| 805.67% | $5.54M | |
| -18.69% | $13.58M | |
| -46.86% | $31.86M | |
| -36.79% | $324.59M | |
| -165.25% | $14.19M | |
| 3.11% | $15.37M | |
| -381.01% | $26.62M | |
| -109.94% | $22.75M | |
| -67.42% | $6.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Processa Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Processa Pharmaceuticals, Inc. (PCSA)?
What is the highest ROE for Processa Pharmaceuticals, Inc. (PCSA)?
What is the 3-year average ROE for Processa Pharmaceuticals, Inc. (PCSA)?
What is the 5-year average ROE for Processa Pharmaceuticals, Inc. (PCSA)?
How does the current ROE for Processa Pharmaceuticals, Inc. (PCSA) compare to its historical average?